Announcements

The “Cancer Biology and Therapeutics” Section of Biomedicines (ISSN: 2227-9059) publishes reviews and original peer-reviewed papers of a high scientific standard, covering all the aspects of innovative cancer therapies. Papers aim to uncover novel therapeutic approaches toward overcoming conventional anticancer drug resistance, a better understanding of the interrelations between cancer and metabolism as well as tumors and microenvironments, along with the discovery of novel diagnostic and prognostic makers. Topics include but are not limited to in vitro and in vivo cancer therapeutic responses, targeted therapies (including metabolism and immunotherapy, such involving CAR-T cells), identification of novel therapeutic targets, and evaluation of novel diagnosis and prognosis markers and the assessment of their impact on morphological, phenotypical, and molecular classifications.

“Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance”
by Maria V. Babak and Dohyun Ahn
Biomedicines 2021, 9(8), 852; https://doi.org/10.3390/biomedicines9080852
Available online: https://www.mdpi.com/2227-9059/9/8/852

“Advances and Limitations of Antibody Drug Conjugates for Cancer”
by Candice Maria Mckertish and Veysel Kayser
Biomedicines 2021, 9(8), 872; https://doi.org/10.3390/biomedicines9080872
Available online: https://www.mdpi.com/2227-9059/9/8/872

“Trifarotene: A Current Review and Perspectives in Dermatology”
by Terenzio Cosio, Monia Di Prete, Roberta Gaziano, Caterina Lanna, Augusto Orlandi, Paolo Di Francesco, Luca Bianchi and Elena Campione
Biomedicines 2021, 9(3), 237; https://doi.org/10.3390/biomedicines9030237
Available online: https://www.mdpi.com/2227-9059/9/3/237

“Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies”
by Hyunkoo Kang, Haksoo Lee, Dahye Kim, Byeongsoo Kim, JiHoon Kang, Hae Yu Kim, HyeSook Youn and BuHyun Youn
Biomedicines 2022, 10(6), 1308; https://doi.org/10.3390/biomedicines10061308
Available online: https://www.mdpi.com/2227-9059/10/6/1308

“The Hallmarks of Glioblastoma: Heterogeneity, Intercellular Crosstalk and Molecular Signature of Invasiveness and Progression”
by Filippo Torrisi, Cristiana Alberghina, Simona D’Aprile, Anna M. Pavone, Lucia Longhitano, Sebastiano Giallongo, Daniele Tibullo, Michelino Di Rosa, Agata Zappalà, Francesco P. Cammarata et al.
Biomedicines 2022, 10(4), 806; https://doi.org/10.3390/biomedicines10040806
Available online: https://www.mdpi.com/2227-9059/10/4/806

“MiR-7 in Cancer Development”
by Petra Korać, Mariastefania Antica and Maja Matulić
Biomedicines 2021, 9(3), 325; https://doi.org/10.3390/biomedicines9030325
Available online: https://www.mdpi.com/2227-9059/9/3/325

“Targeting STAT3 Signaling Pathway in Colorectal Cancer”
by Antonios N. Gargalionis, Kostas A. Papavassiliou and Athanasios G. Papavassiliou
Biomedicines 2021, 9(8), 1016; https://doi.org/10.3390/biomedicines9081016
Available online: https://www.mdpi.com/2227-9059/9/8/1016

“Circulating Tumor Cells: Technologies and Their Clinical Potential in Cancer Metastasis”
by Jerry Xiao, Paula R. Pohlmann, Claudine Isaacs, Benjamin A. Weinberg, Aiwu R. He, Richard Schlegel and Seema Agarwal
Biomedicines 2021, 9(9), 1111; https://doi.org/10.3390/biomedicines9091111
Available online: https://www.mdpi.com/2227-9059/9/9/1111

“CK2 Regulation: Perspectives in 2021”
by Scott E. Roffey and David W. Litchfield
Biomedicines 2021, 9(10), 1361; https://doi.org/10.3390/biomedicines9101361
Available online: https://www.mdpi.com/2227-9059/9/10/1361

“Glycobiology of the Epithelial to Mesenchymal Transition”
by Michela Pucci, Nadia Malagolini and Fabio Dall’Olio
Biomedicines 2021, 9(7), 770; https://doi.org/10.3390/biomedicines9070770
Available online: https://www.mdpi.com/2227-9059/9/7/770

We would appreciate it if you would circulate the link of any of the papers you find appealing into your network.

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://susy.mdpi.com/user/manuscripts/upload/f17a01dbff7541081d1092edf09cd870?form%5Bjournal_id%5D=158.

Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field. Special Issue proposals can be submitted at the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/biomedicines.

Joining the Editorial Board:
We are looking for active scholars who are interested in helping with the selection of submissions and please do not hesitate to get in touch in case you are interested in joining the Editorial Board (biomedicines@mdpi.com).

Biomedicines Editorial Office

MDPI will attend the ASHG Annual Meeting 2023, held in Washington, D.C., USA, from 1 to 5 November 2023.

The ASHG Annual Meeting is the largest human genetics and genomics meeting and exposition in the world. Held in the fall, it provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. Highlights include invited symposia; abstract-driven plenary, platform, and poster sessions; education/trainee workshops; and career opportunities and networking events.

The following MDPI journals will be represented:

• Genes;
• JPM;
• Biomolecules;
• Medicina;
• Diagnostics;
• Cancers;
• Biomedicines;
• Humans;
• Applied Biosciences;
• DNA;
• IJMS;
• Brain Sciences;
• Cardiogenetics;
• Vaccines;
• Life;
• Epigenomes;
• BioTech;
• Biology;
• CIMB;
• Biomedinformatics.

If you plan on attending this conference, please stop by our booth and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.ashg.org/meetings/.

Conference: 2023 China Biomaterials Conference (CSBM2023)
Date: 12–15 October 2023
Booth: #B4

MDPI journals will be attending the 2023 China Biomaterials Conference (CSBM2023) as an exhibitor. This meeting will be held in Chongqing, China, from 12 to 15 October 2023.

The theme of the conference is “Innovative Biomaterials to Protect People's Health”, focusing on the frontiers of biomaterials science, technological innovation, achievement transformation, regulatory science, etc., to discuss and share the latest developments in the current field of biomaterials.

The following MDPI journals will be represented:

• IJMS;
• JFB;
• Bioengineering;
• Biomimetics;
• Marine Drugs;
• Polymers;
• Nanomaterials;
• Biomedicines;
• Micromachines;
• Pharmaceutics;
• Electrochem.

If you plan on attending this conference, please feel free to stop by our booth (#B4) and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit http://2023.csbm.org.cn/index.php/index/index/index.html.

MDPI’s Young Investigator Awards recognize promising young researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2022 in medicine and pharmacology. The winners were selected by the journals’ Award Evaluation Committee.

We would like to warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Biomedicines:

• Yuyan Jiang, Stanford University, USA
• Billy Wai-Lung Ng, Chinese University of Hong Kong, China

Cancers:

• Ashleigh Poh, The Olivia Newton-John Cancer Research Institute, Australia
• Miranda Fidler-Benaoudia, University of Calgary, Canada

Current Oncology:

• Bishal Gyawali, Queen’s University, Canada

Healthcare:

• Shahnawaz Anwer, Hong Kong Polytechnic University, Hong Kong

JCM:

• Jan Bednarsch, Universitätsmedizin Berlin, Germany

JPM:

• Anda Mihaela Naciu, Fondazione Policlinico Universitario Campus Bio-Medico, Italy
• Jerome Lechien, University of Mons, Belgium

Pharmaceuticals:

• Daniele Bertoglio, University of Antwerp, Belgium

Pharmaceutics:

• Gregor Fuhrmann, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany

TropicalMed:

• Haley Adcox, Virginia Commonwealth University, USA

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and a form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to the advancement of their fields.

For more MDPI awards, please click here.

We are proud to recognize the winners of MDPI’s 2022 Travel Awards in medicine and pharmacology category for their outstanding presentations.

MDPI journals regularly offer Travel Awards to encourage talented junior scientists to present their research at academic conferences in specific fields, which helps to enhance their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to congratulate the winners of the 2022 Travel Awards and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Antibiotics:

• Filip Jansåker, Lund University, Lund, Sweden
• Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal

Cancers:

• Diego de Miguel Perez, Icahn School of Medicine at Mount Sinai, USA
• Luigi Russo, Italian Institute of Technology (IIT), Italy

Current Oncology:

• Sneha Sethi, University of Adelaide, Australia
• Xiyin Wang, Indiana University School of Medicine, USA

Dentistry Journal:

• Sonia Nath, University of Adelaide, Australia
• Konstantina Kritikou, Carol Davila University of Medicine and Pharmacy, Romania

Diagnostics:

• Adrien Holzgreve, The University Hospital of Munich, Germany

Hemato:

• Antonella Padella, Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l., Italy

JCDD:

• Susanna Cooper, St. George’s University of London, UK
• Renée Tillie, Maastricht University Medical Center, the Netherlands

JCM:

• Max Lennart Eckstein, University of Bayreuth, Germany
• Lorenzo Bertani, University of Pisa, Italy

Pharmaceutics:

• Yuxue Cao, University of Queensland, Australia
• Flávia Sousa, Italian Institute of Technology, Italy

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form ot recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize the winners for the year 2022 in medicine and pharmacology for their outstanding contributions among the extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievements. MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

• Maxime Pichon, Centre Hospitalier Universitaire de Poitiers, France
• Violeta Popovici, Ovidius University of Constanta, Romania
• Yosra A. Helmy, University of Kentucky, USA

Cancers:

• Antonio G. Solimando, Aldo Moro University of Bari, Italy
• Linlin Guo, The Ohio State University Medical Center, USA
• Ravindra Deshpande, Wake Forest School of Medicine, USA
• Songli Zhu, Fred Hutchinson Cancer Research Center, USA
• Antonella Argentiero, IRCCS Istituto Tumori “Giovanni Paolo II” of Bari, Italy
• Camelia Coada, Alma Mater Studiorum-University of Bologna, Italy
• Chenghui Li, University of Arkansas for Medical Sciences, USA
• Laurentiu Pop, University of Texas Southwestern Medical Center, USA
• Muhammad Fazal Ijaz, Dongguk University, Republic of Korea
• Rafał Watrowski, University of Freiburg, Germany
• Ruben C. Petreaca, The Ohio State University, USA
• Ruchi Roy, Rush University Medical Center, USA
• Salvatore Cocuzza, University of Catania, Italy
• Santosh Kumar Singh, Morehouse School of Medicine, USA
• Sergei Boichuk, Kazan State Medical University, Russia
• Simon John Christoph Soerensen, Stanford University, USA
• Takuya Koie, Gifu University, Japan
• Teresa Rubio-Tomás, Foundation for Research and Technology Hellas, Greece
• Teruki Nii, Kyushu University, Japan
• Tomasz Marjanski, Medical University of Gdansk, Poland

Current Oncology:

• Kristen Haase, The University of British Columbia, Canada
• Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
• Makoto Endo, Kyushu University, Japan

Healthcare:

• Tefera Tadesse, Addis Ababa University, Ethiopia
• Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
• Ryuichi Ohta, Unnan City Hospital, Japan

JCM:

• Henry Sutanto, Cardiovascular Research Institute Maastricht, the Netherlands
• José-María Sánchez-González, University of Seville, Spain
• Emmanouil Kapetanakis, General Hospital of Piraeus “Tzaneio”, Greece

JPM:

• Eleonora Topino, Libera Università Maria Santissima Assunta (LUMSA), Italy
• Rodolfo Reda, Sapienza University of Rome, Italy
• Giulio Francesco Romiti, Sapienza University of Rome, Italy
• Maria Gabriella Melchiorre, IRCCS INRCA—National Institute of Health and Science on Ageing, Italy
• James Walter, ¹Hines VA Hospital, USA; ² Loyola Medical Center, USA

Medical Sciences:

• Vasiliki Tsigkou, Sotiria Hospital, Greece

Pharmaceutics:

• Flavia Zacconi, Pontificia Universidad Católica de Chile, Chile
• Bhupendra Prajapati, Ganpat University, India
• Van-An Duong, Gachon University, Republic of Korea
• Ashish Agrawal, Indian Institute of Technology (BHU), India

Tomography:

• Aydin Eresen, University of California Irvine, USA

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

MDPI’s Best PhD Thesis Awards aim to recognize young scholars who are deemed to have produced the most outstanding PhD thesis in their fields of research and to encourage them to continue their outstanding work and further contributions to their field.

We would like to congratulate the winners of the 2022 Best PhD Thesis Awards in medicine and pharmacology and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Cancers:

• “Uncovering Novel Prognostic and Predictive Epigenetic Biomarkers in Malignant Testicular Germ Cell Tumors”

by João Pedro da Silva Machado Lobo, University of Porto, Portugal

• “Metastatic Recurrence in Colorectal Cancer Arises from Residual EMP1+ Cells”

by Adrià Cañellas Socias, University of Barcelona, Spain

Healthcare:

• “Investigating Novel Aspects of the Blood–Brain Barrier Using High-Resolution Electron Microscopy”

by Shireen Mentor, University of Cape Town, South Africa

JPM:

• “An Epidemiological Approach to Study The Interplay between Genome, Epigenome and Exposome in Women”

by Roberta Magnano San Lio, University of Catania, Italy

Pharmaceutics:

• “Intravitreal Liposomes as Ocular Drug Delivery Systems: Vitreal Interactions, Retinal Permeation and Drug Release Characteristics”

by Shirin Tavakoli, University of Helsinki, Finland

TropicalMed:

• “Microbiome-Mediated Colonization Resistance: Defense against Enteropathogens and Multi-Drug Resistant Organisms”

by Quinten Ducarmon, Leiden University Medical Center, the Netherlands

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

For more MDPI awards, please click here.

The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected review and research papers through a rigorous evaluative process based on criteria such as the scientific merit, overall impact, and quality of presentation of the papers published in the journal.

We are honored to present the winners for the year 2022 in medicine and pharmacology, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications. MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

• “Development and Challenges of Antimicrobial Peptides for Therapeutic Applications”
  by Charles H. Chen and Timothy K. Lu
  Antibiotics 2020, 9(1), 24; https://doi.org/10.3390/antibiotics9010024

• “Antimicrobial Usage and Resistance in Companion Animals: A Cross-Sectional Study in Three European Countries”
  by Philip Joosten, Daniela Ceccarelli, Evelien Odent, Steven Sarrazin, Haitske Graveland, Liese Van Gompel, Antonio Battisti, Andrea Caprioli, Alessia Franco, Jaap A. Wagenaar et al.
  Antibiotics 2020, 9(2), 87; https://doi.org/10.3390/antibiotics9020087

Dentistry Journal:

• “Management of Peri-Implantitis Lesions without the Use of Systemic Antibiotics: A Systematic Review”
  by Ahsen Khan, Ankit Goyal, Scott D. Currell and Dileep Sharma
  Dent. J. 2020, 8(3), 106; https://doi.org/10.3390/dj8030106

• “Associations among Primary Stability, Histomorphometric Findings, and Bone Density: A Prospective Randomized Study after Alveolar Ridge Preservation with a Collagen Cone”
  by Sigmar Schnutenhaus, Werner Götz, Jens Dreyhaupt, Heike Rudolph, Ralph G. Luthardt and Cornelia Edelmann
  Dent. J. 2020, 8(4), 112; https://doi.org/10.3390/dj8040112

Healthcare:

• “Novel Prefrontal Synthesis Intervention Improves Language in Children with Autism”
  by Andrey Vyshedskiy, Edward Khokhlovich, Rita Dunn, Alexander Faisman, Jonah Elgart, Lisa Lokshina, Yuriy Gankin, Simone Ostrovsky, Lauren deTorres, Stephen M. Edelson et al.
  Healthcare 2020, 8(4), 566; https://doi.org/10.3390/healthcare8040566

• “The Effects of Long-Term 40-Hz Physioacoustic Vibrations on Motor Impairments in Parkinson’s Disease: A Double-Blinded Randomized Control Trial”
  by Abdullah Mosabbir, Quincy J. Almeida and Heidi Ahonen
  Healthcare 2020, 8(2), 113; https://doi.org/10.3390/healthcare8020113

JCM:

• “Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US”
  by Donald J. Alcendor
  J. Clin. Med. 2020, 9(8), 2442; https://doi.org/10.3390/jcm9082442

• “Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence”
  by Celestino Sardu, Jessica Gambardella, Marco Bruno Morelli, Xujun Wang, Raffaele Marfella and Gaetano Santulli
  J. Clin. Med. 2020, 9(5), 1417; https://doi.org/10.3390/jcm9051417

• “Estimation of the Transmission Risk of the 2019-nCoy and Its Implication for Public Health Interventions”
  by Biao Tang, Xia Wang, Qian Li, Nicola Luigi Bragazzi, Sanyi Tang, Yanni Xiao and Jianhong Wu
  J. Clin. Med. 2020, 9(2), 462; https://doi.org/10.3390/jcm9020462

JPM:

• “Molecular and Cellular Mechanisms Affected in ALS”
  by Laura Le Gall, Ekene Anakor, Owen Connolly, Udaya G. Vijayakumar, William J. Duddy and Stephanie Duguez
  J. Pers. Med. 2020, 10(3), 101; https://doi.org/10.3390/jpm10030101

• “Postulated Adjuvant Therapeutic Strategies for COVID-19”
  by Anderson O. Ferreira, Hudson C. Polonini and Eli C. F. Dijkers
  J. Pers. Med. 2020, 10(3), 80; https://doi.org/10.3390/jpm10030080

• “Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models”
  by Vincenzo Quagliariello, Margherita Passariello, Domenica Rea, Antonio Barbieri, Martina Iovine, Annamaria Bonelli, Antonietta Caronna, Gerardo Botti, Claudia De Lorenzo and Nicola Maurea
  J. Pers. Med. 2020, 10(4), 179; https://doi.org/10.3390/jpm10040179

Pharmaceutics:

• "Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics”
  by Carla B. Roces, Gustavo Lou, Nikita Jain, Suraj Abraham, Anitha Thomas, Gavin W. Halbert and Yvonne Perrie
  Pharmaceutics 2020, 12(11), 1095; https://doi.org/10.3390/pharmaceutics12111095

• “Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing”
  by Sawittree Sahakijpijarn, Chaeho Moon, John J. Koleng, Dale J. Christensen and Robert O. Williams III
  Pharmaceutics 2020, 12(11), 1002; https://doi.org/10.3390/pharmaceutics12111002

• “Skin Wound Healing Process and New Emerging Technologies for Skin Wound Care and Regeneration”
  by Erika Maria Tottoli, Rossella Dorati, Ida Genta, Enrica Chiesa, Silvia Pisani and Bice Conti
  Pharmaceutics 2020, 12(8), 735; https://doi.org/10.3390/pharmaceutics12080735

Pharmacy:

• “The Role of Hospital and Community Pharmacists in the Management of COVID-19: Towards an Expanded Definition of the Roles, Responsibilities, and Duties of the Pharmacist”
  by Nicola Luigi Bragazzi, Muhammad Mansour, Alessandro Bonsignore and Rosagemma Ciliberti
  Pharmacy 2020, 8(3), 140; https://doi.org/10.3390/pharmacy8030140

• “Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly”
  by David L. Bankes, Hubert Jin, Stephanie Finnel, Veronique Michaud, Calvin H. Knowlton, Jacques Turgeon and Alan Stein
  Pharmacy 2020, 8(2), 87; doi.org/10.3390/pharmacy8020087

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

We had the pleasure of speaking with Dr. Alireza Dolatshahi-Pirouz, Section Board Member of the “Biomedical Engineering in Human Health” Section in Biomedicines (ISSN: 2227-9059), to discuss his experience with Biomedicines and his research interest in the field of biomechanics and tissue engineering. Dr. Dolatshahi-Pirouz is currently an associate professor at the Department of Health Technology, Technical University of Denmark, Denmark. We hope you enjoy the interview!

We had the pleasure of speaking with Prof. Dr. Swee Hin Teoh, Editorial Board Member of Biomedicines (ISSN: 2227-9059), to discuss his experience with Biomedicines and the recent research trends in the field.

Prof. Dr. Swee-Hin Teoh graduated with a BEng and Ph.D. from Monash University, Australia, in 1978 and 1981, respectively. He then worked at the National University of Singapore from 1982 to 2022. He is presently an Emeritus Professor at Nanyang Technological University (NTU). He is a Fellow of the Academy of Engineers Singapore. Prof. Dr. Teoh is one of a few scientists who has brought research from the lab to the clinic and to public listing. He was at the Nanyang Technological University Singapore (NTU) from 2012 to 2022 and was honored with the President’s Chair School of Chemical and Biomedical Engineering, and was jointly appointed Professor of bioengineering at Lee Kong Chian School of Medicine, NTU Singapore. Recently, he was listed among the World’s Top 2% Scientists by scholars from Stanford University. The Stanford rankings reflect the significant influence and research excellence of Prof. Dr. Teoh, who is committed to furthering knowledge for the benefit of society.

Prof. Dr. Teoh is known for the clinical translation of 3D-printed bioresorbable scaffolds for bone tissue engineering. This device has FDA approval and has been implanted in more than 60,000 patients globally, and the company Osteopore successfully went public in Australia in 2019. His pioneering work in fracture and wear of biomaterials is well recognized and highly cited. He has won a number of major awards, such as the Golden Innovation Award from Far East Economic Review, and the Institute of Engineers Singapore’s Prestigious Engineering Achievement Award in 2004. Majoring in materials engineering at Monash University, Melbourne, Australia, his research journey focused on translating materials research to biomedical benefits. He has over 260 research publications and 22 patents. He was the Founding Chief Engineer of the Skin Research Institute of Singapore, a unique entity that is highly interdisciplinary and involves NTU, A*Star and Singapore Hospital (TTSH). He undertook pioneering work to develop a unique bioreactor with electromagnetic energy to study bone growth and organ biocompatibility in chick embryos. His Web of Science citation record is 11,382, and he has an h-index of 51. His Google Scholar citations equal 91334, and his h-index is 136. He has also won numerous Excellent Teaching Awards. Presently he is the Designate Director at the Centre for Advanced Materials Engineering in Medicine (CAMEM) and Distinguished Cheung Kong Professor at the School of Materials and Engineering, Hunan University, People’s Republic of China.

We hope you enjoy the interview.

1. Why did you decide to work for Biomedicines? Tell us about the journal and your role there.
Biomedicines reminds me of the great scientist Louis Pasteur, a chemist-turned-microbiologist who became the father of modern medicine; a legendary man who inspired me. The multidisciplinary nature of Biomedicines, the focus on disease research to benefit and impact society and the rapid speed of publication of original work and the assistance of able editorial managers are some of the reasons why I chose the journal. I started as a Guest Editor in the Special Issue “Scaffolds for Bone Tissue Engineering”, a topic I have researched for more than 20 years. Bone diseases are important problems to solve, especially for the aging population experienced worldwide.

2. Why should scientists submit their manuscripts in Biomedicines? And how do you think open access impacts authors?
A survey where Nobel Laureates published their works will show that it is not just the numerical high impact factor of a journal based on citation but on other factors such as the impact on society, commonly measured by Alternative (A) index in social media, news, web, YouTube, and also the Composite (C) index based on an interdisciplinary team, resilience in pursuing details, especially in experimentation, as opposed to just discovering something novel which sometimes depends on serendipity. I think Biomedicines has some of these qualities that attract scientists who are seeking a mature audience, especially in translational medicine with good science. This is also of interest to industries. Open access is attractive as it allows a larger audience to quickly read the published works.

3. Tell us more about your first publishing experience. How do you begin the process of writing a paper?
I always begin by asking why anyone would be interested in reading my paper if it does not address a compelling issue in medicine. After identifying the issue, I would ask myself whether I have assembled a credible multidisciplinary team to look at the solution and whether we have demonstrated a repeatable science-based experimental technique. One also needs to ask are the results based on a sound statistical analysis and are the conclusions moderated, which otherwise may seem overenthusiastic, blind to other shortcomings.

4. What are some current challenges in this field?
Some current challenges in bone tissue engineering are the cocktail of stem cells that need to be packed in the 3D printed scaffolds to address long-term viability in vascularization and tissue remodeling, which is dependent on the biomechanics and electromagnetic stimulation of the new bone construct from the surrounding environment.

5. Finally, do you have any advice for young researchers?
Before embarking on a Ph.D. topic please do a detailed problem-based study with a team of interdisciplinary researchers. Do as much content learning via the internet and seek experts’ opinions on various issues, especially if you are pursuing biomedical research. Formulating the right questions is an important first step. It would be great if a young researcher would meditate on the words of wisdom of the great scientist Louis Pasteur—“Chance favors a prepared mind”—and spend time studying his autobiography and capture his passion for standing up for truths in science through experimentation and prove skeptics wrong no matter where they are placed in the hierarchy of their profession.

We are thankful for Prof. Dr. Teoh’s time and his support for Biomedicines.

Prof. Dr. Swee Hin Teoh’s contact information:
E-mail: teohsh@ntu.edu.sg